Your browser doesn't support javascript.
loading
Cardiac complications during pregnancy are better predicted with the modified WHO risk score.
Pijuan-Domènech, A; Galian, L; Goya, M; Casellas, M; Merced, C; Ferreira-Gonzalez, I; Marsal-Mora, J R; Dos-Subirà, L; Subirana-Domènech, M T; Pedrosa, V; Baró-Marine, F; Manrique, S; Casaldàliga-Ferrer, J; Tornos, P; Cabero, L; Garcia-Dorado, D.
Afiliación
  • Pijuan-Domènech A; Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain. Electronic address: tonyapijuan@hotmail.com.
  • Galian L; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Goya M; Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Casellas M; Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Merced C; Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Ferreira-Gonzalez I; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Marsal-Mora JR; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Dos-Subirà L; Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Subirana-Domènech MT; Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital of Sant Pau I la Santa Creu, Barcelona, Spain.
  • Pedrosa V; Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Baró-Marine F; Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Manrique S; Department of Anesthesiology, Hospital Valld'Hebron, Barcelona, Spain.
  • Casaldàliga-Ferrer J; Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d'Hebron, Barcelona, Spain; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Tornos P; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
  • Cabero L; Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Garcia-Dorado D; Department of Cardiology, University Hospital Valld'Hebron, Barcelona, Spain.
Int J Cardiol ; 195: 149-54, 2015 Sep 15.
Article en En | MEDLINE | ID: mdl-26043149
ABSTRACT
BACKGROUND/

OBJECTIVE:

Several risk scores (RSs) have been used to stratify risk of cardiac complications (CCs) in pregnant patients with heart disease. We aimed to compare and contrast the accuracy of several RSs for predicting CC in this population.

METHODS:

Prospective inclusion of all consecutive pregnant patients with heart disease, and follow-up until 6 months postpartum. CCs were defined as primary if admission was required due to heart failure, arrhythmia or thromboembolic events, and secondary if the decline in NYHA class compared with baseline was >2 or urgent invasive cardiac procedures were needed. The discriminatory power of each RS was assessed by the area-under-the receiver-operating characteristic (ROC) curve (AUC).

RESULTS:

179 patients, mean age 32 years, accounted for 13.4% of CC (primary 11.7%, secondary 1.7%); the main diagnosis was congenital heart disease (CHD) in 68% followed by valvulopathies in 16%, arrhythmia in 7% and myocardiopathies in 5%. 22% (n=40) were classified as mWHO=1, 59% (n=105) mWHO=2 including subgroup 2-3, 14% (n=26) mWHO=3 and 4%(n=7) mWHO=4; 1 patient was unclassifiable. mWHO showed a better AUC (0.763) than CARPREG (0.67). For the CHD population, ZAHARA RS showed an AUC of 0.74, and Khairy an AUC of 0.632.

CONCLUSIONS:

mWHO was better at predicting CC than CARPREG; mWHO was also better at predicting CC than the specific CHD RS in the CHD subgroup. PRACTICE There are an increasing number of pregnant women with HD. IMPLICATIONS Improved prediction of CC risk during pregnancy can provide better preconception assessment in women with HD.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arritmias Cardíacas / Complicaciones Cardiovasculares del Embarazo / Cardiopatías Congénitas / Enfermedades de las Válvulas Cardíacas / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Int J Cardiol Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arritmias Cardíacas / Complicaciones Cardiovasculares del Embarazo / Cardiopatías Congénitas / Enfermedades de las Válvulas Cardíacas / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Int J Cardiol Año: 2015 Tipo del documento: Article